{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:30:03Z","timestamp":1787009403256,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1-R35-NS07211-01"],"award-info":[{"award-number":["1-R35-NS07211-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1-R35-NS07211-01"],"award-info":[{"award-number":["1-R35-NS07211-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging insights from numerous laboratories have revealed important roles for nonneoplastic cells in the development and progression of brain tumors. One of these nonneoplastic cellular constituents, glioma-associated microglia (GAM), represents a unique population of brain monocytes within the tumor microenvironment that have been reported to both promote and inhibit glioma proliferation. To elucidate the role of GAM in the setting of low-grade glioma (LGG), we leveraged RNA sequencing meta-analysis, genetically engineered mouse strains, and human biospecimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publicly available disease-associated microglia (DAM) RNA-seq datasets were used, followed by immunohistochemistry and RNAScope validation. CD11a-deficient mouse microglia were used for in vitro functional studies, while LGG growth in mice was assessed using anti-CD11a neutralizing antibody treatment of Neurofibromatosis type 1 (Nf1) optic glioma mice in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified Itgal\/CD11a enrichment in GAM relative to other DAM populations, which was confirmed in several independently generated murine models of Nf1 optic glioma. Moreover, ITGAL\/CD11A expression was similarly increased in human LGG (pilocytic astrocytoma) specimens from several different datasets, specifically in microglia from these tumors. Using CD11a-knockout mice, CD11a expression was shown to be critical for murine microglia CX3CL1 receptor (Cx3cr1) expression and CX3CL1-directed motility, as well as glioma mitogen (Ccl5) production. Consistent with an instructive role for CD11a+ microglia in stromal control of LGG growth, antibody-mediated CD11a inhibition reduced mouse Nf1 LGG growth in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, these findings establish ITGAL\/CD11A as a critical microglia regulator of LGG biology relevant to future stroma-targeted brain tumor treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noab130","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:17:16Z","timestamp":1621898236000},"page":"14-26","source":"Crossref","is-referenced-by-count":35,"title":["RNA sequence analysis reveals ITGAL\/CD11A as a stromal regulator of murine low-grade glioma growth"],"prefix":"10.1093","volume":"24","author":[{"given":"Amanda","family":"De Andrade Costa","sequence":"first","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jit","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Cobb","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Sanapala","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Scheaffer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-0964","authenticated-orcid":false,"given":"Sonika","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-5045","authenticated-orcid":false,"given":"David H","family":"Gutmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"2022010521001413200_CIT0001","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conb.2017.10.009","article-title":"Neuronal activity in the glioma microenvironment","volume":"47","author":"Johung","year":"2017","journal-title":"Curr Opin Neurobiol."},{"issue":"10","key":"2022010521001413200_CIT0002","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","article-title":"RNA sequencing of tumor-associated microglia reveals Ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth","volume":"17","author":"Solga","year":"2015","journal-title":"Neoplasia."},{"issue":"10","key":"2022010521001413200_CIT0003","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/neuonc\/noz080","article-title":"Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia","volume":"21","author":"Guo","year":"2019","journal-title":"Neuro Oncol."},{"issue":"1","key":"2022010521001413200_CIT0004","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41467-020-15770-3","article-title":"Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth","volume":"11","author":"Guo","year":"2020","journal-title":"Nat Commun."},{"issue":"11","key":"2022010521001413200_CIT0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/neuonc\/noaa148","article-title":"JAM-A functions as a female microglial tumor suppressor in glioblastoma","volume":"22","author":"Turaga","year":"2020","journal-title":"Neuro Oncol."},{"key":"2022010521001413200_CIT0006","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ccell.2019.05.003","article-title":"Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-null glioma","volume":"35","author":"Chen","year":"2019","journal-title":"Cancer Cell"},{"issue":"8","key":"2022010521001413200_CIT0007","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat Genet."},{"issue":"5","key":"2022010521001413200_CIT0008","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"Pfister","year":"2008","journal-title":"J Clin Invest."},{"issue":"6123","key":"2022010521001413200_CIT0009","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science."},{"issue":"1","key":"2022010521001413200_CIT0010","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/s41467-020-16167-y","article-title":"YAP1\/TAZ drives ependymoma-like tumour formation in mice","volume":"11","author":"Eder","year":"2020","journal-title":"Nat Commun."},{"issue":"3","key":"2022010521001413200_CIT0011","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet."},{"issue":"2","key":"2022010521001413200_CIT0012","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.23813","article-title":"Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation","volume":"73","author":"Pong","year":"2013","journal-title":"Ann Neurol."},{"issue":"9","key":"2022010521001413200_CIT0013","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/hmg\/ddm059","article-title":"Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth","volume":"16","author":"Daginakatte","year":"2007","journal-title":"Hum Mol Genet."},{"issue":"1","key":"2022010521001413200_CIT0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neo.2018.11.007","article-title":"KIAA1549-BRAF expression establishes a permissive tumor microenvironment through NF\u03baB-mediated CCL2 production","volume":"21","author":"Chen","year":"2019","journal-title":"Neoplasia."},{"issue":"1","key":"2022010521001413200_CIT0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/NEN.0b013e3182032d37","article-title":"Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth","volume":"70","author":"Simmons","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"2022010521001413200_CIT0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"issue":"2","key":"2022010521001413200_CIT0017","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"issue":"6","key":"2022010521001413200_CIT0018","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-009-0506-3","article-title":"Histopathologic predictors of pilocytic astrocytoma event-free survival","volume":"117","author":"Tibbetts","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"9","key":"2022010521001413200_CIT0019","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/hmg\/ddw039","article-title":"NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1","volume":"25","author":"Toonen","year":"2016","journal-title":"Hum Mol Genet."},{"issue":"6","key":"2022010521001413200_CIT0020","first-page":"808","article-title":"Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction","volume":"19","author":"Toonen","year":"2017","journal-title":"Neuro Oncol."},{"key":"2022010521001413200_CIT0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.isci.2018.10.011","article-title":"Microglia induce PDGFRB expression in glioma cells to enhance their migratory capacity","volume":"9","author":"Wallmann","year":"2018","journal-title":"iScience."},{"issue":"6151","key":"2022010521001413200_CIT0022","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/331086a0","article-title":"ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells","volume":"331","author":"Makgoba","year":"1988","journal-title":"Nature."},{"issue":"4","key":"2022010521001413200_CIT0023","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2010.03.007","article-title":"T cell receptor \u201cinside-out\u201d pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes","volume":"32","author":"Raab","year":"2010","journal-title":"Immunity."},{"issue":"6","key":"2022010521001413200_CIT0024","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.4049\/jimmunol.179.6.4053","article-title":"ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration","volume":"179","author":"Allingham","year":"2007","journal-title":"J Immunol."},{"issue":"3","key":"2022010521001413200_CIT0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","article-title":"Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients","volume":"67","author":"Rodriguez","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"2022010521001413200_CIT0026","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-Oncology"},{"issue":"5","key":"2022010521001413200_CIT0027","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/glia.23575","article-title":"CD11a expression distinguishes infiltrating myeloid cells from plaque-associated microglia in Alzheimer\u2019s disease","volume":"67","author":"Shukla","year":"2019","journal-title":"Glia."},{"issue":"3","key":"2022010521001413200_CIT0028","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat Neurosci."},{"key":"2022010521001413200_CIT0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.neuron.2019.02.006","article-title":"Microglial phagocytosis of newborn cells is induced by endocannabinoids and sculpts sex differences in juvenile rat social play","volume":"102","author":"VanRyzin","year":"2019","journal-title":"Neuron"},{"issue":"12","key":"2022010521001413200_CIT0030","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"2022010521001413200_CIT0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"2022010521001413200_CIT0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2018.12.006","article-title":"Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing","volume":"101","author":"Li","year":"2019","journal-title":"Neuron"},{"issue":"7","key":"2022010521001413200_CIT0033","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"9","key":"2022010521001413200_CIT0034","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"5","key":"2022010521001413200_CIT0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","article-title":"Microglia heterogeneity in the single-cell era","volume":"30","author":"Masuda","year":"2020","journal-title":"Cell Rep."},{"issue":"6448","key":"2022010521001413200_CIT0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1126\/science.aau9100","article-title":"Targeting microglia in brain disorders","volume":"365","author":"Priller","year":"2019","journal-title":"Science."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noab130\/38836942\/noab130.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/1\/14\/42074965\/noab130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/1\/14\/42074965\/noab130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:02:30Z","timestamp":1641398550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/24\/1\/14\/6286081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,5,27]]},"published-print":{"date-parts":[[2022,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noab130","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,5,27]]}}}